Zacks Investment Management’s Vaxart VXRT Stock Holding History

Zacks Investment Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-38,098	Closed	-$337K	–	568
2020 Q2	$337K	Buy	+38,098	New	+$109K	0.01%	429

Other funds holding VXRT

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Zacks Investment Management's VXRT Position: Q3 2020 in Review

Zacks Investment Management sold out of Vaxart (VXRT) in Q3 2020, closing a stake of 38,098 shares — an estimated $337K sold.

Zacks Investment Management first reported a position in VXRT in Q2 2020 and held it in 1 quarter. The position peaked at $337K in Q2 2020. 130 funds tracked by Wall St. Rank hold VXRT as of Q3 2020.

Zacks Investment Management reported no remaining Vaxart position as of Q3 2020 after selling out during the quarter.
Zacks Investment Management sold 38,098 Vaxart shares in Q3 2020, an estimated $337K.
Zacks Investment Management first reported a position in Vaxart in Q2 2020 and held it in 1 quarter.
Zacks Investment Management's Vaxart position peaked at $337K in Q2 2020.
130 funds tracked by Wall St. Rank held Vaxart as of Q3 2020.

Based on Zacks Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.